Tumor type | Samples | Expression (tumor vs. normal) | Kaplan–Meier analysis (impact of DANCR dysregulation) | Univariate/multivariate cox regression | Association of dysregulation of DANCR with clinical data | References |
---|---|---|---|---|---|---|
Bladder cancer | 120 PTN | Up | Shorter OS and DFS | High levels of DANCR were an independent prognostic factor for shorter OS | LN metastasis status, tumor stage, histological grade | [8] |
106 PTN | Up | – | – | Higher histological grade and advanced TNM stage | [9] | |
Breast cancer | TCGA dataset 60 triple-negative (TNBC) type, 15 HER2 type, 15 Luminal A type, and 15 Luminal B type, and 10 normal breast tissues | Up in TNBC | Shorter OS | – | Bigger tumor size | [27] |
30 PTN | Up | – | – | – | [28] | |
TCGA database 46 PTN | Up | – | – | Advanced tumor grades or lymph node metastasis | [29] | |
46 PTN | Up | – | – | – | [34] | |
57 PTN | Up | Shorter OS | – | – | [35] | |
35 TNBC tissues, 52 adjacent normal breast tissues and 25 non-TNBC breast tissues | Up-regulation of TUFT1(which induces DANCR expression) in TNBC tissues | Shorter OS | – | Lower differentiation degree of TNBC cells | [36] | |
120 BC patients, 70 BBD patients, and 105 healthy controls | Up in BC patients | Shorter OS | DANCR was found to be an independent risk factor for BC | Lymph node metastasis, ER status, HER2 status, and TNM stage | [90] | |
Five GEO datasets: 657 breast tumors 50 TNBC and 50 non-TNBC tissues | Up in TNBC tissues | – | – | OXC1/lnc-FOXCUT/lnc-DANCR axis is involved in the aggressive features of triple-negative breast tumors | [93] | |
63 PTN | Up | Shorter OS | – | TNM stages | [37] | |
Breast cancer | TCGA database: 790 BCa tissues and 104 normal tissues 12 TNBC patients and 4 normal controls | Up | – | – | – | [38] |
2192 samples from 21 studies | Up | – | – | – | [94] | |
Cervical cancer | 65 PTN | Up | Shorter OS | – | Advanced stage, larger tumors, advanced FIGO stage and lymph node metastasis | [39] |
82 PTN | Up | Shorter OS | – | Large tumor size, advanced FIGO stage | [40] | |
112 PTN | Up | – | – | Histological type, tumor staging, infiltrating muscle depth and lymphatic metastasis | [41] | |
33 PTN | Down-regulation of miR-665 (a target of DANCR) Up-regulation of DANCR | Shorter OS | – | Tumor size, distant metastasis, advanced TNM stage | [42] | |
Cholangiocarcinoma | 40 PTN | Up | Shorter OS | – | Tumor size, TNM state and lymph node metastasis | [43] |
GEO database (GSE76297) 17 PTN | Up | – | – | – | [44] | |
Colon cancer | 35 PTN | Up | – | – | – | [21] |
69 PTN | Up | Shorter OS | – | – | [22] | |
Colorectal cancer | 50 PTN | Up | – | – | TNM stage and positive lymph node metastasis | [46] |
80 colorectal cancer patients and 10 normal colon tissues | Up | Shorter OS | – | Clinical stages | [47] | |
40 PTN | Up | – | – | – | [48] | |
GEO (GSE126092) and TCGA databases 15 PTN | Up | – | – | TNM stages | [95] | |
47 PTN | Up | – | – | Clinical stage, nodal and metastasis classifications, and liver metastasis | [49] | |
Colorectal cancer | 104 PTN | Up | Shorter OS and DFS | DANCR was found to be an independent poor prognostic factor for both OS and DFS | TNM stage, histologic grade, and lymph node metastasis | [96] |
Endometrial carcinoma | 27 patients and 18 normal controls | Up | – | – | – | [50] |
Esophageal squamous cell carcinoma | 51 PTN Data of KMPlot tool (55 patients) and data of LinkedOmics tool (178 patients) | Down-regulation of miR-33a-5p (a target of DANCR) | Shorter OS | – | Advanced TNM stage and lymph node metastasis | [52] |
32 PTN | Up | – | – | – | [53] | |
Gastric cancer | 14 DDP-sensitive GC tissues and 14 DDP-resistant GC tissues | Up in DDP-resistant | – | – | – | [30] |
TCGA database 86 PTN | Up | Shorter OS | – | Tumor size, TNM stage, invasion depth, and lymph node metastasis | [31] | |
65 PTN 55 patients and 39 healthy controls | Up | – | – | Tumor size, TNM stage, lymphatic metastasis and invasion depth | [32] | |
118 PTN | Up | Shorter OS | – | – | [54] | |
Glioma | 33 PTN | Up | Shorter OS | – | Clinical grading and tumor size | [55] |
TCGA dataset 82 glioma tissues and 10 normal brain tissues | Up | – | – | Tumor grading | [56] | |
86 PTN | Up | Shorter OS | – | Histological type and WHO grade | [57] | |
47 glioma patients and 14 normal tissues | Up | – | – | Advanced tumor grade | [59] | |
TCGA database 40 tumor tissues and 40 normal tissues | Up-regulation of IGF2BP2 (which increases DANCR stability) | – | – | _ | [61] | |
Hepatocellular carcinoma | 62 PTN | Up | Shorter OS | – | – | [17] |
TCGA and GEPIA database 66 PTN | Up | Shorter OS | – | – | [18] | |
13 HCC patients, 10 hepatitis, 10 with cirrhosis, and 10 normal database | Up in HCC patients | Shorter OS | High levels of DANCR were an independent prognostic factor | – | [19] | |
STARBASE and GEPIA database | Up | Shorter OS | – | – | [20] | |
52 PTN 52 HCC patients, 29 patients with chronic hepatitis, 22 cirrhosis and 43 healthy controls | Up in HCC patients | – | – | Microvascular and liver capsule invasion of HCC | [62] | |
23 PTN | Down | – | – | – | [92] | |
Lung cancer | 32 lung cancer tissues and 11 normal lung tissues | Up | Shorter OS | Â | Grade | [10] |
GSE130779: 8 PTN 48 PTN | Up | Shorter OS | Â | TNM stage and lymph node metastasis | [11] | |
100 patients | Up | – |  | – | [13] | |
34 PTN | Up | – |  | – | [12] | |
45 PTN | Up | Shorter OS | Â | Advanced TNM stage, lymph node metastasis and a larger tumor size | [63] | |
TCGA database: lung 706 adenocarcinoma and 626 lung squamous cell carcinoma samples | Up | – |  | – | [14] | |
40 PTN | Up | – |  | – | [64] | |
64 PTN | Up | Shorter OS | Â | Larger tumor size, advanced TNM stage and lymph node metastasis | [65] | |
128 PTN | Up | – |  | – | [66] | |
40 PTN | Up | – |  | – | [67] | |
Nasopharyngeal carcinoma | 10 PTN 100 PTN | Up | Shorter OS | – | – | [70] |
14 tumor tissues and 9 normal tissues 212 tumor tissue | Up | Shorter OS and DFS and metastasis-free survival | DANCR expression and N stage were found to be independent prognostic factors | Lymph node metastasis | [73] | |
Oral squamous cell carcinoma | 86 PTN | Up | Shorter OS | – | Histological grade, clinical staging and lymph node metastasis | [75] |
Osteosarcoma | 95 PTN | Up | Shorter OS | Â | advanced stage, lymph node metastasis and distant metastasis | [3] |
34 PTN | Up | – |  | – | [2] | |
Osteosarcoma | 109 PTN | Up | – |  | Lymph node metastasis and distant metastasis | [4] |
45 PTN | Up | – |  | – | [5] | |
40 PTN | Up-regulation of METTL3 (DANCR could be a target of METTL3) | – | – | – | [6] | |
Ovarian cancer | 20 PTN | Up | – | – | – | [78] |
20 PTN | Up | – | – | TNM staging and metastasis | [79] | |
Pancreatic cancer | 30 PTN | Up | – | – | – | [24] |
50 PTN | Up | Shorter OS | – | Tumor size, TNM stage, and lymph nodal metastasis | [25] | |
206 PTN | Up | Shorter OS and PFS | DANCR was found to be an independent poor prognostic factor for both OS and PFS | Vascular invasion, advanced T stage, lymph node metastasis and advanced TNM stage | [80] | |
68 PTN | Up | – | – | TNM stage, N stage, and recurrence rates | [26] | |
Papillary thyroid cancer | GEO database (GSE33630, GSE50901, and GSE66783) 76 PTN | Down | – | DANCR was found to be an independent protective factor for TNM stage | TNM stage | [91] |
112 PTN | Up | – | – | Age and micro carcinoma | [97] | |
Prostate cancer | 36 PTN | Up | – | – | – | [81] |
40 PTN | Up | Shorter OS | – | Grade and metastasis | [82] | |
53 patients and 47 healthy controls | Up | Shorter OS | – | PSA, Gleason score, T stage, N stage and M stage | [83] | |
15 DTX-sensitive and 14 DTX-resistant PC tissues | Up in DTX-resistant | – | – | – | [84] | |
GEO database (GSE2547) | Up | – | – | – | [85] | |
Renal cell carcinoma | 24 PTN | Down | – | – | – | [86] |
Retinoblastoma | 57 patients and matched health controls | Up | Shorter OS | – | – | [87] |